Healome Therapeutics raises €460K Seed round
27 April 2022· Birmingham, United Kingdom· health, biotech, materials, b2b, deep_hardware
The funding was used to establish the company's own laboratories at the Birmingham Research Park and prepare for Phase I human trials.
Investors
LeadSFC Capital
Also participating
Innovate UK
About Healome Therapeutics
Stage
Series A
Headquarters
Birmingham, United Kingdom
Founded
2021
Team Size
1–5
Sectors
healthbiotechmaterialsb2bdeep_hardware